Medication info
Telmisartan Plus Tablet 40/12.5 mg (Telmisartan, Hydrochlorothiazide)

Telmisartan Plus Tablet 40/12.5 mg (Telmisartan, Hydrochlorothiazide)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Genupharma Co., Ltd.
Appearance
Oval-shaped tablet composed of two layers, white and pink, with possible pink specks in the white layer.
Packaging
30 tablets/box (10 tablets/Alu-Alu X 3)
Approval status
Active

MFDS item code 201001023 · Notified 2010.01.29 · Insurance code 698001110

Summary

Main use
Treats essential hypertension inadequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide 40/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide 80/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide 80/25mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. No dosage adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. No dosage adjustment is required.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Genupharma Co., Ltd.

Efficacy & effects

Treats essential hypertension inadequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension. It helps effectively lower blood pressure by being administered additionally to patients whose blood pressure is not adequately controlled with Telmisartan alone. This leads to improved blood pressure management and contributes to reducing the risk of cardiovascular complications.

How to take

Adult dose

Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide 40/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide 80/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide 80/25mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. No dosage adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. No dosage adjustment is required.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, particularly in the second and third trimesters, as it can cause serious harm to the fetus. It should not be administered to pregnant or breastfeeding women, and treatment should be discontinued immediately if pregnancy is confirmed. It should not be given to patients with an allergy to any ingredients in this medication or those with severely impaired liver or kidney function. Elderly patients, those with high potassium levels, or those with poor liver function should exercise caution while using this medication. Due to the increased risk of skin cancer, excessive sun exposure should be avoided, and immediate consultation with a physician is advisable if there are any skin abnormalities. During the course of this treatment, side effects such as dizziness, hypotension, and electrolyte imbalances may occur, and if symptoms arise, they should be reported immediately. When taken with other antihypertensives or diuretics, periodic monitoring of blood pressure, kidney function, and electrolyte levels is required. This medication may cause drowsiness or dizziness when driving or operating machinery, so caution is needed. In cases of overdose, symptoms such as hypotension, electrolyte abnormalities, and muscle cramps may occur, necessitating immediate medical attention. It is not recommended for children or adolescents under 18, as safety has not been established.

Side effects

  • Hypotension
  • neonatal skull formation deficiency
  • anuria
  • kidney failure
  • oligohydramnios
  • limb spasms
  • craniofacial malformation
  • pulmonary hypoplasia
  • premature
  • intrauterine growth retardation
Show 223 more
  • patent ductus arteriosus
  • bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorder
  • dizziness
  • syncope
  • perceptual disturbance
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory pain
  • lung inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • hepatic impairment
  • vascular edema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasm
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hypersensitivity
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • taste disturbance
  • eczema
  • drug rash
  • toxic skin rash
  • arthralgia
  • renal dysfunction
  • myasthenia
  • influenza-like illness
  • increased blood creatinine
  • increased blood uric acid
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypomagnesemia
  • hyperlipidemia
  • decreased appetite
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • jaundice
  • bile stasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • acute renal failure
  • diabetes
  • acute respiratory distress syndrome
  • pancreatitis
  • erythema multiforme
  • myasthenia
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • floating sensation
  • lip and hand tremors
  • hypersensitivity
  • visual impairment
  • hypotension
  • tachycardia
  • hypokalemia
  • hypochloremia
  • dehydration
  • nausea
  • somnolence
  • muscle cramps
  • cardiac arrhythmia
  • elevated serum lithium levels
  • acute renal failure
  • acute functional renal failure
  • pulmonary edema
  • fever
  • worsening lung condition
  • hypotension
  • abdominal pain
  • nausea
  • diarrhea
  • orthostatic hypotension
  • serum electrolyte imbalance
  • decreased urine output
  • nausea
  • vomiting
  • hypokalemia
  • hyponatremia
  • hypomagnesemia
  • hypoglycemia
  • thrombocytopenia
  • vascular edema
  • vasculitis
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • anaphylaxis
  • hypersensitivity
  • toxic skin rash
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • acute respiratory distress syndrome
  • acute renal failure
  • lung inflammation
  • pulmonary edema
  • acute angle-closure glaucoma
  • choroidal effusion
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • increased blood creatinine
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • elevated liver enzymes
  • decreased hemoglobin
  • thrombocytopenia
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • anaphylactic reaction
  • hypersensitivity
  • hypokalemia
  • hyperlipidemia
  • hyponatremia
  • hyperuricemia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • jaundice
  • bile stasis
  • rash
  • urticaria
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • muscle spasm
  • acute renal failure
  • erectile dysfunction
  • myasthenia
  • fever
  • dizziness
  • diarrhea
  • cough
  • nausea
  • headache
  • gastrointestinal bleeding
  • esophagitis
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • floating sensation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Oval-shaped tablet composed of two layers, white and pink, with possible pink specks in the white layer.

Package unit

30 tablets/box (10 tablets/Alu-Alu X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.